4.5 Article

Comparison of EQ-5D and SF-6D utilities in Pompe disease

Journal

QUALITY OF LIFE RESEARCH
Volume 24, Issue 4, Pages 837-844

Publisher

SPRINGER
DOI: 10.1007/s11136-014-0833-2

Keywords

Preference-based measure of health; EQ-5D; SF-6D; Orphan disease, Pompe disease

Funding

  1. Netherlands Organization for Health Research and Development (ZonMw) [152001005]

Ask authors/readers for more resources

Comparative studies between Euroqol-5D (EQ-5D) and ShortForm 6D (SF-6D) utilities have been performed for a number of diseases, but not yet for orphan diseases. Pompe disease is an orphan disease with a prevalence of < 5/10,000, characterized by impaired ambulatory and pulmonary functioning. We compared the psychometric properties of EQ-5D and SF-6D in patients with this disease and assessed their convergent validity, discriminative ability and sensitivity to change. EQ-5D utilities and SF-6D utilities were computed using the UK value set. Dimensions and utilities of the two instruments were compared by correlation coefficients and descriptive statistics. We assessed whether EQ-5D and SF-6D were able to discriminate between different levels of severity and examined sensitivity to change for patients with multiple observations. Correlations between theoretically related dimensions of the EQ-5D and SF-6D were highly significant and were moderate to strong (range rho = 0.409-0.564). Utility values derived from the two instruments were similar (mean EQ-5D = 0.670; mean SF-6D = 0.699) and correlated strongly (rho = 0.591). Discriminative properties were somewhat better for EQ-5D; mean changes and effect sizes were better for SF-6D. Overall, we conclude that both instruments appear to be equally appropriate with respect to assessing utilities in Pompe disease, but neither of them performed excellently. The descriptive system of the SF-6D describes health states for Pompe disease more accurately. EQ-5D showed better discriminative properties. The SF-6D performed better with respect to sensitivity to change.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Developmental

Caring for Children with an Autism Spectrum Disorder: Factors Associating with Health- and Care-Related Quality of Life of the Caregivers

Leontine W. ten Hoopen, Pieter F. A. de Nijs, Jorieke Duvekot, Kirstin Greaves-Lord, Manon H. J. Hillegers, Werner B. F. Brouwer, Leona Hakkaart-van Roijen

Summary: The mental health, coping abilities, and parenting stress of caregivers are crucial in caring for children with ASD.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2022)

Review Health Care Sciences & Services

Strategies for Implementing Occupational eMental Health Interventions: Scoping Review

Renaldo M. Bernard, Claudia Toppo, Alberto Raggi, Marleen de Mul, Carlota de Miquel, Maria Teresa Pugliese, Christina M. van der Feltz-Cornelis, Ana Ortiz-Tallo, Luis Salvador-Carulla, Sue Lukersmith, Leona Hakkaart-van Roijen, Dorota Merecz-Kot, Kaja Staszewska, Carla Sabariego

Summary: This scoping review analyzes 31 publications on occupational eMental health interventions and identifies 98 implementation strategies, 114 barriers, and 131 facilitators. The study also provides 19 initial recommendations for improving the implementation of occupational eMental health interventions.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Article Environmental Sciences

In Search for Comparability: The PECUNIA Reference Unit Costs for Health and Social Care Services in Europe

Susanne Mayer, Michael Berger, Alexander Konnopka, Valentin Brodszky, Silvia M. A. A. Evers, Leona Hakkaart-van Roijen, Mencia R. Guiterrez-Colosia, Luis Salvador-Carulla, A-La Park, William Hollingworth, Lidia Garcia-Perez, Judit Simon

Summary: Improving the efficiency of mental healthcare service delivery requires valid and comparable data, including unit costs. The PECUNIA project aims to harmonize the international unit cost development and has produced 36 externally validated, standardized reference unit costs for five health and social care services across multiple countries. These unit costs are largely comparable, but some limitations exist due to data-driven divergences in costing parameters. By adopting a uniform methodology and definitions, cross-country comparability can be increased, leading to improved evidence-based policy guidance. The PECUNIA unit costs are freely available and can significantly improve the quality and feasibility of future economic evaluations.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Allergy

The Disease Burden and Societal Costs of Hereditary Angioedema

Laure M. Fijen, Philip C. G. Klein, Danny M. Cohn, Tim A. Kanters

Summary: This study aims to establish the entire burden of hereditary angioedema (HAE) which includes disease control, treatment satisfaction, reductions in quality of life, and societal costs. A cross-sectional survey was conducted on adult patients with HAE under treatment at the Dutch national center of reference, and the results provide valuable information for reimbursement decisions for HAE treatments.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Pharmacology & Pharmacy

Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young

Gabor Kovacs, David Nagy, Laszlo Szilberhorn, Tamas Zelei, Zsolt Gaal, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balazs Nagy

Summary: This study aimed to assess the cost-effectiveness of MODY screening strategies in Hungary, comparing recent genetic test with no routine screening for MODY. A simulation model combining a decision tree and an individual-level Markov model was used to evaluate the costs per quality-adjusted life year of screening strategies. Stratifying patients based on age and insulin treatment followed by a risk assessment questionnaire, laboratory test, and genetic testing was found to be the most cost-effective strategy, saving EUR 12 and generating 0.0047 quality-adjusted life years gained per screened patient. This strategy could be considered for reimbursement, especially in countries with limited resources.

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries

Laszlo Szilberhorn, Tamas Zelei, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balazs Nagy

Summary: Correct diagnosis of MODY is important to provide appropriate treatment. Screening with the MODY calculator then genetic testing is considered cost-effective, and the addition of autoantibody testing can replace no screening. The budget impact ranges from 0.001% to 0.025% of annual public healthcare spending.

PERSONALIZED MEDICINE (2023)

Editorial Material Pharmacology & Pharmacy

HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead

Maureen Rutten-van Moelken, Matthijs Versteegh, Balazs Nagy, Sarah Wordsworth

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems

Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, Laszlo Szilberhorn, Tamas Zelei, Balazs Nagy, Sarah Wordsworth, Apostolos Tsiachristas

Summary: The cost-effectiveness and budget impact of introducing extended DPYD testing with ToxNav prior to capecitabine/5-fluorouracil in metastatic breast cancer patients in the UK, The Netherlands, and Hungary were examined. ToxNav was cost-effective in all three countries and resulted in budget savings in the UK and The Netherlands.

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK

Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Moelken, Laszlo Szilberhorn, Tamas Zelei, Balazs Nagy, Sarah Wordsworth, Apostolos Tsiachristas

Summary: This study aimed to assess the cost-effectiveness of ToxNav (c), a multivariant genetic test, for screening DPYD and personalized chemotherapy dosing in metastatic breast cancer patients in the UK. Results showed that ToxNav (c) was dominant over standard of care, providing additional quality-adjusted life years and cost savings per patient. Sensitivity analysis further supported the effectiveness of the ToxNav (c) strategy.

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Cost-effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries

Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Laszlo Szilberhorn, Tamas Zelei, Balazs Nagy, Rositsa Koleva-Kolarova, Sarah Wordsworth, Maureen Rutten-van Molken

Summary: This study investigated the cost-effectiveness of the histology-independent treatment entrectinib for cancer patients with NTRK gene fusions. The analysis conducted in England, Hungary, and The Netherlands found that all testing strategies resulted in a negative net benefit to society. This could be partly explained by the rarity of NTRK gene fusions.

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation

Rositsa Koleva-Kolarova, Laszlo Szilberhorn, Tamas Zelei, Heleen Vellekoop, Balazs Nagy, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, Sarah Wordsworth, Apostolos Tsiachristas

Summary: This study examines the financing and reimbursement barriers of personalized medicine in Europe and proposes important recommendations, such as establishing legal foundations, creating databases, using financial-based agreements, regulating price and reimbursement transparency, as well as fostering a business-friendly environment and attractive market for innovation.

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies

Balazs Nagy, Tamas Zelei, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Moelken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Laszlo Szilberhorn

Summary: The HEcoPerMed consortium developed a methodological guidance for economic evaluations in personalized medicine, and health economic models were developed to analyze the recommendations. The models addressed most of the recommendations and identified essential recommendations in each study.

PERSONALIZED MEDICINE (2023)

Review Economics

Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review

Marieke Krol, Nikkie Hosseinnia, Werner Brouwer, Leona Hakkaart van Roijen

Summary: This paper presents a systematic literature review on compensation mechanisms and multiplier effects in economic evaluations of health interventions. The review suggests that these mechanisms have a significant impact on productivity losses and costs, but more research is needed to clarify their features, measurement methods, and valuations.

PHARMACOECONOMICS (2023)

Article Health Care Sciences & Services

The Impact of Video-Based Educational Materials with Voiceovers on Preferences for Glucose Monitoring Technology in Patients with Diabetes: A Randomised Study

Ian P. Smith, Chiara L. Whichello, Esther W. de Bekker-Grob, Maureen P. M. H. Rutten-van Moelken, Jorien Veldwijk, G. Ardine de Wit

Summary: This study found that providing patients with video-based educational materials does not necessarily lead to higher patient engagement or different preference outcomes compared to traditional text-based information. Increasing patient engagement with educational materials should be a focus of future research.

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2023)

Review Multidisciplinary Sciences

Assessing the impact of caregiving on informal caregivers of adults with a mental disorder in OECD countries: A systematic literature review of concepts and their respective questionnaires

Leonarda G. M. Bremmers, Isabelle N. Fabbricotti, Eleonora S. Graler, Carin A. Uyl-de Groot, Leona Hakkaart-van Roijen

Summary: This study aimed to identify and review concepts and questionnaires used to assess the impact of caregiving for adults with a mental disorder. Multiple concepts and dimensions were found, with non-specific questionnaires being commonly used. Important concept clusters included mental health, caregiving burden, other caregiving consequences, family impact, and overall health-related outcomes.

PLOS ONE (2022)

No Data Available